# A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study

> **NCT05990998** · PHASE1,PHASE2 · COMPLETED · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 38 (actual)

## Conditions studied

- Tumor Positron-Emission Tomography

## Interventions

- **DRUG:** 68Ga-DOTATATE and 68Ga-FAPI

## Key facts

- **NCT ID:** NCT05990998
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-20
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-09-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05990998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05990998, "A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05990998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*